Search results for “Demyelinating Disorder” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 213 patents, we discovered top 32 key players by total patent application. Biogen MA, Inc., Plexxikon, Inc., Sanofi-Aventis Deutschland GmbH are dominant in this area. They take 45.07% of the total patent filing.
Biogen MA, Inc.
Massachusetts, United States
Patent: 60
Plexxikon, Inc.
California, United States
Patent: 22
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 14
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 11
ImCyse SA
Liège, Belgium
Patent: 10
Aventis Pharma SARL
France
Patent: 9
Antisoma, Inc.
Massachusetts, United States
Patent: 9
Aimsco Ltd.
Kent, United Kingdom
Patent: 8
Novartis AG
Basel-Stadt, Switzerland
Patent: 7
OncoImmune, Inc.
United States
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 45 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing Biogen MA, Inc., ImCyse SA, OncoImmune, Inc. take 68.89% of patent filing during this period.
Biogen MA, Inc.
Massachusetts, United States
Patent: 14
ImCyse SA
Liège, Belgium
Patent: 10
OncoImmune, Inc.
United States
Patent: 7
Children's National Hospital (District of Columbia)
District of Columbia, United States
Patent: 7
Institut National de la Santé et de la Recherche Médicale
France
Patent: 4
Rush University Medical Center
Illinois, United States
Patent: 2
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
Bayern, Germany
Patent: 2
The Scripps Research Institute
California, United States
Patent: 1
GIBH
Guangdong Sheng, China
Patent: 1
Auckland Uniservices
Australia
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 45 patents in last 5 years, we discover 11 new entrants. ImCyse SA, OncoImmune, Inc., Children's National Hospital (District of Columbia) are the most active new entrants in this area.
ImCyse SA
Liège, Belgium
Patent: 10
OncoImmune, Inc.
United States
Patent: 7
Children's National Hospital (District of Columbia)
District of Columbia, United States
Patent: 7
Rush University Medical Center
Illinois, United States
Patent: 2
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
Bayern, Germany
Patent: 2
The Scripps Research Institute
California, United States
Patent: 1
GIBH
Guangdong Sheng, China
Patent: 1
Auckland Uniservices
Australia
Patent: 1
Frequency Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Université Claude Bernard Lyon 1
France
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 47 patents, we discovered top 6 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, The University of Chicago, Regents of the University of Colorado are dominant in this area. They take 70.21% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 11
The University of Chicago
Illinois, United States
Patent: 10
Regents of the University of Colorado
Colorado, United States
Patent: 3
Emory University
Georgia, United States
Patent: 2
The Scripps Research Institute
California, United States
Patent: 1
Université Claude Bernard Lyon 1
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: